FBMKLCI 1646.22
-10.32pts (-0.62%)
Volume 766.7mil Value RM1,651mil
1) KLCI fell to a low of 1641.74 (-14.8pts) inline with
the key regional markets as recent rally were halted on concern EU zone
economic growth remain subdued and fears of China policy makers stepping up
restrictions on property investors.
Local market were also weighted by the impending GE13 with investors
looking to economic data for trading directions. Market breadth turned negative
with decliners doubling gainers 477:225. Future closed 1640 (6points discount)
2) Heavyweights: CIMB-1.93% RM7.11, GENTING-1.60% RM9.80,
YTL-3.6% RM1.60, DIGI-1.08% RM4.60, IOICORP-1.25% RM4.75, RHBCAP-3.55% RM8.15,
AXIATA-0.47% RM6.36, UMW-1.48% RM13.36
3) DBT: SANICHI 65mil @ RM0.07 (26.86% PUC, 40%
discount), CSL 8.75mil @ RM0.60 (16.5% premium)
4) Situational:
EKIB+20% RM0.44: Emas Kiara Industries Bhd has received a
takeover offer from deputy executive chairman Wong Kong Foo to acquire the
remaining shares he does not own in the company at 45 sen a share. Wong and
persons acting in concert with him held a combined 48.77% stake comprising
43.52 million shares following several corporate exercises is obliged to
undertake a conditional take-over offer to buy at 45 sen each the remaining
40.27% or 35.939 million shares not held by the offeror and persons who have
irrevocably undertaken not to accept the offer.
5) IHH
Announced today via GHK Hospital Ltd ( a 60%-owned
subsidiary of Parkway HK Holdings Limited wholly owned by IHH whilst Media Year
Investments Limited owns the remaining 40%
signed a definitive Memorandum of Agreement and Conditions of Sale (Land
Grant) as well as Service Deed with The Government of Hong Kong Special
Administrative Region, upon having successfully won the bid by way of public
tender for the acquisition of a site identified as Aberdeen Inland Lot No. 458,
Nam Fung Path, Wong Chuk Hang, Hong Kong with a total site area and maximum
gross floor area of approximately 27,500 square metres and 46,750 square metres
respectively, as well as the construction, development and operation of a
private hospital on the Site.It is estimated that the Project will involve a
capital investment of approximately HKD5 billion(i)) which is inclusive of land
cost for the acquisition of the Site amounting to HKD1.688 billion.
The said capital investment, including land cost, will be
funded by internally generated funds and bank borrowings. The Site is expected to be fully developed for hospital
use in late 2016 when the Hospital is scheduled to commence operations. The
Hospital will provide a full range of clinical service with more than 15
specialties, including general medicine, general surgery, orthopaedics, and
gynaecology, and others, with a total bed capacity of 500 beds.
The Li Ka Shing Faculty of Medicine of The University of
Hong Kong will act as the clinical partner of the Hospital and oversee its
clinical governance, professional standards, appointment of doctors and the
training of doctors, nurses and allied healthcare staff
+ve as it expands its geographical reach from its
domineering position in Malaysia, Singapore and Turkey with future growth in
China, Vietnam, India, UAE leveraging on its underutilized balance sheet with a
net gearing of only 7%.
